Healthcare
Leading advisory services for the healthcare industry.
Healthcare is ever changing – doctors are embracing technology now more than ever, and as a society, we are living longer and becoming more health-conscious. This growing demand for healthcare opens up a window of opportunities for companies in this market.
Oppenheimer’s Healthcare Investment Banking Group is comprised of dedicated teams focused on the life sciences, medical technology, and healthcare services sectors. We deliver expert-level industry guidance coupled with decades of transaction experience, to assist our clients in achieving their strategic and financial goals.
We have extensive experience serving as both sell side and buy side advisors as well as in underwriting and placing equity and debt offerings for public and privately-held companies. Over the last decade, our healthcare banking professionals have completed financings that raised approximately $30 billion and advised on over 300 merger and acquisition deals valued at approximately $13 billion.*
Our healthcare banking professionals focus on the following sub-sectors:
- Biotechnology specialty pharmaceuticals and generics
- Healthcare information technology
- Healthcare services
- Medical devices life science tools and diagnostics
Michael A. Margolis, R.Ph.
Title:Co-Head of Healthcare, Head of Healthcare Life Sciences
Marc Cabrera
Title:Co-Head of Healthcare, Head of Healthcare Services
Guy Cohen
Title:Managing Director, Israel & EMEA Healthcare
Matthew Dormer
Title:Managing Director
Warren Dunnavant
Title:Managing Director, Life Sciences
Jonathan Fassberg
Title:Managing Director
Brian Korb
Title:Managing Director
Stefan Loren, Ph.D.
Title:Managing Director, Life Sciences
Don Ritucci
Title:Managing Director, Healthcare M&A
Meredith Sondler-Bazar
Title:Managing Director
Healthcare
SPAC Business Combination
Capital Markets Advisor
See All Transactions Opens in a new window